Experience of left atrial appendage closure performed under conscious sedation
- 1 September 2014
- journal article
- research article
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 23 (4), 394-398
- https://doi.org/10.1177/0218492314548231
Abstract
Background: Percutaneous left atrial appendage closure is typically performed with transesophageal echocardiography guidance under general anesthesia. This study was performed to investigate the safety, feasibility, procedural characteristics, and outcomes of performing this procedure under conscious sedation without an anesthetist’s support. Methods: Eleven patients (6 men; mean age 64.6 ± 10.4 years) with atrial fibrillation (median CHA2DS2VASc score 3) underwent transesophageal echocardiography-guided left atrial appendage occlusion under conscious sedation. Results: All patients had successful procedures. Procedural duration and fluoroscopic times were 93.8 ± 25.3 and 16.2 ± 6.5 min, respectively. The doses of midazolam and fentanyl required were 5.4 ± 1.8 mg and 54.5 ± 27 µg, respectively. No complications arose from conscious sedation. Watchman (mean size 29 ± 5 mm) and Amplatzer Cardiac Plug (mean size 24 ± 4 mm) devices were implanted in 5 and 6 patients, respectively. One patient had device displacement due to over-compression on day one, and underwent successful percutaneous retrieval without any long-term sequelae. Warfarin was stopped in all patients after day 45, with transesophageal echocardiography showing optimal device position without a significant jet flow. In a mean follow-up of 12.1 ± 10.1 months, no thromboembolic complications were observed. Conclusions: Percutaneous left atrial appendage occlusion can be performed safely and effectively under conscious sedation. This approach will significantly reduce the complexity and costs of this increasingly performed procedure.Keywords
This publication has 16 references indexed in Scilit:
- Percutaneous Left Atrial Appendage Closure With the AMPLATZER Cardiac Plug Device in Patients With Nonvalvular Atrial Fibrillation and Contraindications to Anticoagulation TherapyJournal of the American College of Cardiology, 2013
- Left Atrial Appendage Closure With the Watchman Device in Patients With a Contraindication for Oral AnticoagulationJournal of the American College of Cardiology, 2013
- Amplatzer left atrial appendage occlusion: Single center 10‐year experienceCatheterization and Cardiovascular Interventions, 2013
- Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial FibrillationCirculation, 2013
- Perioperative and anaesthetic-related mortality in developed and developing countries: a systematic review and meta-analysisThe Lancet, 2012
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillationEuropean Heart Journal, 2012
- Are anaesthetics toxic to the brain?British Journal of Anaesthesia, 2011
- Safety of Percutaneous Left Atrial Appendage ClosureCirculation, 2011
- Left atrial appendage closure with amplatzer cardiac plug in atrial fibrillation: Initial european experienceCatheterization and Cardiovascular Interventions, 2010
- Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trialThe Lancet, 2009